These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6974165)

  • 1. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
    Leigh DA; Bradnock K; Marriner JM
    J Antimicrob Chemother; 1981 Mar; 7(3):229-36. PubMed ID: 6974165
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis.
    Ulmer WT; Zimmermann I
    J Int Med Res; 1981; 9(5):372-7. PubMed ID: 7028534
    [No Abstract]   [Full Text] [Related]  

  • 3. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB; Lang SD; Downey DJ; Anderson MP
    N Z Med J; 1982 Aug; 95(713):542-5. PubMed ID: 6752781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentin (amoxycillin and clavulanic acid) in the treatment of urinary tract infections.
    Leigh A
    Scott Med J; 1982; 27 Spec No.():S28-34. PubMed ID: 6984778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.
    Ball AP; Geddes AM; Davey PG; Farrell ID; Brookes GR
    Lancet; 1980 Mar; 1(8169):620-3. PubMed ID: 6102627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of clavulanic acid in a combined formulation on the concentration of amoxycillin in the urine of patients with urinary tract infections.
    Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):12A-13A. PubMed ID: 7046103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR; LeFrock JL
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH; Tay L; Yeo M; Feng PH
    Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience with intravenous Augmentin in the treatment of paediatric infections.
    Ploechl E; Huber EG
    J Int Med Res; 1986; 14(3):153-7. PubMed ID: 3636248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial.
    Levenstein JH
    S Afr Med J; 1982 Jul; 62(5 Spec No):16A-20A. PubMed ID: 7046104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I; Horiguchi S; Hatae T
    Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
    Focht J; Klietmann W; Heilmann HD
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
    Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with amoxicillin and clavulanic acid of urinary tract infections in patients with spinal injuries].
    Du Plessis DJ; Celliers D; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):8A-11A. PubMed ID: 6979806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Haruta T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The history and background of Augmentin.
    Rolinson GN
    S Afr Med J; 1982 Jul; 62(5 Spec No):3A-4A. PubMed ID: 6979804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentin (amoxycillin-clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly.
    Gallacher G; Erwin L; Scott PJ; Sleigh JD
    J Infect; 1986 May; 12(3):229-33. PubMed ID: 3522749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.